Lisdexamfetamine, often referred to as Vyvanse, is a scheduled drug approved in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and adults . The medication functions as a https://sandozlisdexamfetaminepr522657.blogofoto.com/75026483/lisdexamfetamine-in-the-nation-a-detailed-guide